HO2 — DR Horton Income Statement
0.000.00%
- €39.33bn
- €43.77bn
- $36.80bn
- 47
- 49
- 47
- 42
Annual income statement for DR Horton, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
| 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 20,311 | 27,774 | 33,480 | 35,460 | 36,801 | 
| Cost of Revenue | |||||
| Gross Profit | 4,961 | 7,900 | 10,565 | 9,431 | 9,590 | 
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 17,328 | 22,418 | 25,850 | 29,146 | 30,517 | 
| Operating Profit | 2,983 | 5,356 | 7,630 | 6,315 | 6,285 | 
| Net Income Before Taxes | 2,983 | 5,356 | 7,630 | 6,315 | 6,285 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,381 | 4,191 | 5,896 | 4,795 | 4,806 | 
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2,374 | 4,176 | 5,858 | 4,746 | 4,756 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,374 | 4,176 | 5,858 | 4,746 | 4,756 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 6.34 | 11.5 | 16.7 | 14 | 14.5 | 
| Dividends per Share |